Ghost Tree Capital as of Dec. 31, 2013
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 62 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Allergan Inc option | 6.8 | $11M | 100k | 111.08 | |
| Gilead Sciences (GILD) | 6.2 | $10M | 135k | 75.10 | |
| Gilead Sciences Inc option | 4.6 | $7.5M | 100k | 75.10 | |
| Edwards Lifesciences Corp option | 4.0 | $6.6M | 100k | 65.76 | |
| Nuvasive Inc Comm on | 4.0 | $6.5M | 200k | 32.33 | |
| Gilead Sciences Inc option | 3.5 | $5.6M | 750.00 | 7510.67 | |
| Bristol Myers Squibb (BMY) | 3.3 | $5.3M | 100k | 53.15 | |
| Vertex Pharmaceuticals Inc option | 3.0 | $4.8M | 65k | 74.31 | |
| Biogen Idec (BIIB) | 2.8 | $4.5M | 16k | 279.56 | |
| Spectranetics Corporation | 2.7 | $4.4M | 175k | 25.00 | |
| Teva Pharmaceutical Inds Ltd option | 2.5 | $4.0M | 100k | 40.08 | |
| Accuray Incorporated (ARAY) | 2.4 | $3.9M | 450k | 8.70 | |
| Thoratec Corp | 2.2 | $3.7M | 100k | 36.60 | |
| Cubist Pharmaceuticals | 2.1 | $3.4M | 50k | 68.88 | |
| Prothena (PRTA) | 2.1 | $3.4M | 130k | 26.52 | |
| Mazor Robotics Ltd. equities | 2.1 | $3.4M | 175k | 19.52 | |
| Dyax | 2.1 | $3.4M | 450k | 7.54 | |
| Insmed (INSM) | 2.1 | $3.4M | 200k | 17.00 | |
| HeartWare International | 2.1 | $3.3M | 36k | 93.90 | |
| Zimmer Holdings (ZBH) | 2.0 | $3.3M | 35k | 93.20 | |
| Arrowhead Research | 1.8 | $3.0M | 275k | 10.85 | |
| Community Health Systems (CYH) | 1.7 | $2.7M | 70k | 39.27 | |
| Quidel Corporation | 1.6 | $2.6M | 85k | 30.89 | |
| Puma Biotechnology (PBYI) | 1.6 | $2.6M | 25k | 103.52 | |
| Idera Pharmaceuticals | 1.6 | $2.5M | 550k | 4.63 | |
| Sagent Pharmaceuticals | 1.6 | $2.5M | 100k | 25.38 | |
| GenMark Diagnostics | 1.6 | $2.5M | 190k | 13.29 | |
| Bruker Corporation (BRKR) | 1.4 | $2.3M | 115k | 19.77 | |
| Hologic | 1.4 | $2.2M | 100k | 22.35 | |
| Sangamo Biosciences (SGMO) | 1.3 | $2.1M | 150k | 13.89 | |
| Auxilium Pharmaceuticals Inc option | 1.3 | $2.1M | 100k | 20.73 | |
| Lannett Company | 1.2 | $2.0M | 60k | 33.10 | |
| Tornier Nv | 1.2 | $1.9M | 100k | 18.79 | |
| Volcano Corporation | 1.1 | $1.9M | 85k | 21.85 | |
| Clovis Oncology | 1.1 | $1.8M | 30k | 60.27 | |
| Celgene Corporation | 1.0 | $1.7M | 10k | 169.00 | |
| Tearlab Corp | 1.0 | $1.6M | 175k | 9.34 | |
| Unilife US | 0.9 | $1.5M | 350k | 4.40 | |
| Hologic (HOLX) | 0.9 | $1.5M | 65k | 22.35 | |
| BioMarin Pharmaceutical (BMRN) | 0.9 | $1.4M | 20k | 70.35 | |
| Jazz Pharmaceuticals (JAZZ) | 0.8 | $1.3M | 10k | 126.60 | |
| NxStage Medical | 0.8 | $1.3M | 125k | 10.00 | |
| OraSure Technologies (OSUR) | 0.8 | $1.3M | 200k | 6.29 | |
| Air Methods Corporation | 0.7 | $1.2M | 20k | 58.25 | |
| Tandem Diabetes Care | 0.7 | $1.2M | 45k | 25.78 | |
| Geron Corporation (GERN) | 0.7 | $1.1M | 235k | 4.74 | |
| Masimo Corporation (MASI) | 0.6 | $1.0M | 35k | 29.23 | |
| Biotelemetry | 0.6 | $993k | 125k | 7.94 | |
| Ocera Therapeutics | 0.6 | $974k | 75k | 12.99 | |
| Flamel Technologies | 0.6 | $966k | 120k | 8.05 | |
| Nanosphere | 0.6 | $916k | 400k | 2.29 | |
| Ariad Pharmaceuticals | 0.6 | $887k | 130k | 6.82 | |
| Endologix | 0.5 | $872k | 50k | 17.44 | |
| Agilent Technologies Inc C ommon (A) | 0.5 | $858k | 15k | 57.20 | |
| D Horizon Pharma | 0.5 | $762k | 100k | 7.62 | |
| Dynavax Technologies Corporation | 0.4 | $686k | 350k | 1.96 | |
| Ophthotech | 0.4 | $647k | 20k | 32.35 | |
| DepoMed | 0.3 | $529k | 50k | 10.58 | |
| Chelsea Therapeutics International | 0.3 | $444k | 100k | 4.44 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.2 | $341k | 175k | 1.95 | |
| Discovery Laboratories | 0.1 | $225k | 100k | 2.25 | |
| Wright Med Group Inc right 03/01/2019 | 0.0 | $18k | 55k | 0.33 |
